Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cancers|October 14, 2022
Risk Factors for Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-AnalysisClaudia Mellenthin, Vasile Daniel Balaban, Ana Dugic, et al.Plos One|June 17, 2021
Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literatureSarah Peisl, Claudia Mellenthin, Lucie Vignot, et al.Biomedicines|July 27, 2022
The Clinical Utility of Soluble Serum Biomarkers in Autoimmune Pancreatitis: A Systematic ReviewAna Dugic, Cristina Verdejo Gil, Claudia Mellenthin, et al.Medizinische Klinik (Munich, Germany : 1983)|June 29, 2006
HFE mutations in idiopathic dilated cardiomyopathyAndreas Erhardt, Claudia Mellenthin, Christian Perings, et al.Endocrinology, Diabetes & Metabolism Case Reports|November 8, 2021
Fructose-induced severe hypertriglyceridemia and diabetes mellitus: a cautionary taleAna Dugic, Michael Kryk, Claudia Mellenthin, et al.Journal of Hepatology|February 15, 2003
HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosisAndreas Erhardt, Andrea Maschner-Olberg, Claudia Mellenthin, et al.JMIR Research Protocols|December 15, 2025
IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional StudyClaudia Mellenthin, Fabien Schaller, Lucie Vignot, et al.Surgical Innovation|March 12, 2021
Patient-Reported Outcome Measures in Colorectal Surgery: Construction of Core Measures Using Open-Source Research MethodAlaa El-Hussuna, Ines Rubio-Perez, Monica Millan, et al.Pageof 1